| 1 |
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study [J]. Crit Care Med, 2006, 34(2): 344-353.
|
| 2 |
Shao R, Fang Y, Yu H, et al. Monocyteprogrammed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study [J]. Crit Care, 2016, 20(1): 124.
|
| 3 |
Chang K, Svabek C, Vazquez-Guillamet C, et al. Targeting the programmed cell death 1: Programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis [J]. Crit Care, 2014, 18(1): R3.
|
| 4 |
Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure [J]. JAMA, 2011, 306(23): 2594-2605.
|
| 5 |
Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, et al. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis [J]. Crit Care, 2012, 16(3): R112.
|
| 6 |
Chang KC, Burnham CA, Compton SM, et al. Blockade of the negativeco-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis [J]. Crit Care, 2013, 17(3): R85.
|
| 7 |
Kox WJ, Bone RC, Krausch D, et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle [J]. Arch Intern Med, 1997, 157(4): 389-393.
|
| 8 |
Mathias B, Szpila BE, Moore FA, et al. A review of GM-CSF therapy in sepsis [J]. Medicine (Baltimore), 2015, 94(50): e2044.
|
| 9 |
Giacomini E, Severa M, Cruciani M, et al. Dual effect of thymosin a 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists [J]. Expert Opin Biol Ther, 2015, 15(Suppl 1): S59-S70.
|
| 10 |
Yang X, Qian F, He HY, et al. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro [J]. Braz J Med Biol Res, 2012, 45(1): 25-32.
|
| 11 |
Liu F, Wang HM, Wang T, et al. The efficacy of thymosin a1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials [J]. BMC Infect Dis, 2016, 16: 488.
|
| 12 |
Zhang DZ, Zhou Y, Cheng QH. Effects of combined thymosin and hydrocortisone on immune response in septic mice [J]. Int J Clin Exp Med, 2015, 8(8): 12989-12994.
|
| 13 |
Zhu Y, Li N, He ZY, et al. Effects of Xuebijing on endothelial functions and serum inflammatory factors in patients with severe sepsis [J]. Chin J Clin Res, 2016, 29 (6): 746-748, 752.
|
| 14 |
Shao M, Liu B, Wang JQ, et al. Effect of Xuebijing injection on T helper 17 and CD4+CD25+ regulatory T cells in patients with sepsis [J]. Chin Crit Care Med, 2011, 23 (7): 430-434.
|
| 15 |
Ren Y, Wu SX, Yin X, et al. A clinical study of improvement of immunologic function in patients with old age sepsis treated by astragalus injection [J]. Chin J TCM WM Crit Care, 2014, 21 (5): 323-327.
|
| 16 |
李志军, 刘清泉, 沈洪, 等. 脓毒症中西医结合诊治专家共识 [J]. 中华危重病急救医学, 2013, 25(4): 194-197.
|
| 17 |
中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014) [J]. 中华危重病急救医学, 2015, 27(6): 401-426.
|
| 18 |
王新芳, 张宇忠, 任丽薇, 等. 加昧生脉饮注射液对内毒素休克大鼠肺组织肿瘤坏死因子-α,白细胞介素-1β和核转录因子-κB含量的影响 [J]. 中国药师, 2011, 14(8): 1078-1081.
|
| 19 |
Inoue S, Bo L, Bian J, et al. Dose-dependent effect of anti-CTLA-4 on survival in sepsis [J]. Shock 2011, 36: 38-44.
|
| 20 |
Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, et al. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis [J]. Crit Care, 2012, 16: R112.
|
| 21 |
Unsinger J, McGlynn M, Kasten KR, et al. IL-7 promotes T cell viability trafficking and functionality and improves survival in sepsis [J]. J Immunol, 2010, 184(7): 3768-3779.
|
| 22 |
Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment [J]. J Clin Invest, 2009, 119: 997-1007.
|
| 23 |
Budagian V, Bulanova E, Paus R, et al. IL-15/IL-15 receptor biology: a guided tour through an expanding universe [J]. Cytokine Growth Factor Rev, 2006, 17(4): 259-280.
|
| 24 |
Anguille S, Smits EL, Cools N, et al. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties [J]. J Transl Med, 2009, 7: 109.
|
| 25 |
Inoue S, Unsinger J, Davis CG, et al. IL-15 prevent apoptosis reverses innate and adaptive immune dysfunction and improves survival in sepsis [J]. J Immunol, 2010, 184(3): 1401-1409.
|
| 26 |
Wodnar-Filipowicz A. Flt3 ligand: role in control of hematopoietic and immune functions of the bone marrow [J]. News Physiol Sci, 2003, 18: 247-251.
|
| 27 |
Bohannon J, Cui W, Sherwood E, et al. Dendritic cell modification of neutrophil responses to infection after burn injury [J]. J Immunol, 2010, 185(5): 2847-2853.
|
| 28 |
In situ vaccine for low-grade lymphoma: combination of intratumoral Flt3L and poly-ICLC with low-dose radiotherapy [EB/OL].
URL
|
| 29 |
Kumaresan PR, Manuri PR, Albert ND, et al. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection [J]. Proc Nat Acad Scie USA, 2014, 111(29): 10660-10665.
|
| 30 |
Dotti G, Gottschalk S, Savoldo B, et al. Design and development of therapies using chimeric antigen receptor-expressing T cells [J]. Immunol Rev, 2014, 257(1): 107-126.
|
| 31 |
Yang WL, Ma G, Zhou M, et al. Combined administration of human ghrelin and human growth hormone attenuates organ injury and improves survival in aged septic rats [J]. Mol Med, 2016, 22: 124-135.
|
| 32 |
Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways [J]. Curr Opin Pharmacol, 2010, 10(4): 408-424.
|
| 33 |
Koo GC, Huang C, Camacho R, et al. Immune enhancing effect of a growth hormone secretagogue [J]. J Immunol, 2001, 166(6): 4195-4201.
|
| 34 |
Narula T, de Boisblanc BP. Ghrelin in critical illness [J]. Am J Respir Cell Mol Biol, 2015, 53(4): 437-442.
|
| 35 |
Zhou M, Aziz M, Ochani M, et al. The protective role of human ghrelin in sepsis: restoration of CD4 T cell proliferation [J]. PLoS One, 2018, 13(7): e0201139.
|
| 36 |
Schorr CA, Dellinger RP. The Surviving Sepsis Campaign: past present and future [J]. Trends Mol Med, 2014, 20(4): 192-194.
|